-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS INC - FDA REVIEW OF POVETACICEPT BLA EXPECTED TO BE COMPLETED IN SIX MONTHS - SEC FILING

Reuters·03/31/2026 20:20:21

Please log in to view news